These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7139117)

  • 1. Growth in the Prader-Willi syndrome.
    Holm VA; Nugent JK
    Birth Defects Orig Artic Ser; 1982; 18(3B):93-100. PubMed ID: 7139117
    [No Abstract]   [Full Text] [Related]  

  • 2. The nutrition and growth over a 10 month period of an infant with the Prader-Willi syndrome.
    Morgan JB; Rolles CJ
    Hum Nutr Appl Nutr; 1984 Aug; 38(4):304-7. PubMed ID: 6490399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary intervention in the first four years prevents abnormal weight gain but negatively affects height development in Prader-Willi syndrome.
    Schmidt H; Schwarz HP; Enders A
    Acta Paediatr; 2001 Apr; 90(4):468-9. PubMed ID: 11332946
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
    Ritzén EM; Lindgren AC; Hagenäs L; Marcus C; Müller J; Blichfeldt S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():345-9. PubMed ID: 10698600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using stable isotopes to assess reduced physical activity of individuals with Prader-Willi syndrome.
    Davies PS; Joughin C
    Am J Ment Retard; 1993 Nov; 98(3):349-53. PubMed ID: 8292311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
    Eiholzer U; Meinhardt U; Gallo C; Schlumpf M; Rousson V; l'Allemand D
    J Pediatr; 2009 Feb; 154(2):225-9. PubMed ID: 18822426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standards for selected anthropometric measurements in Prader-Willi syndrome.
    Butler MG; Meaney FJ
    Pediatrics; 1991 Oct; 88(4):853-60. PubMed ID: 1896298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
    Eiholzer U; Schlumpf M; Nordmann Y; l'Allemand D
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1441-4. PubMed ID: 11837497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
    Höybye C
    Acta Paediatr; 2007 Mar; 96(3):410-3. PubMed ID: 17407467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular histology in boys with Prader-Willi syndrome: fertile or infertile?
    Vogels A; Moerman P; Frijns JP; Bogaert GA
    J Urol; 2008 Oct; 180(4 Suppl):1800-4. PubMed ID: 18721940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
    Tauber M; Cutfield W
    Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prader-Willi syndrome: medical, emotional and cognitive facets].
    Gross-Tsur V; Landau YE
    Harefuah; 2000 May; 138(10):833-6, 910. PubMed ID: 10883249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative scoliosis treatment in patients with Prader-Willi syndrome.
    Weiss HR; Bohr S
    Stud Health Technol Inform; 2008; 140():314-7. PubMed ID: 18810044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain developmental abnormalities in Prader-Willi syndrome detected by diffusion tensor imaging.
    Yamada K; Matsuzawa H; Uchiyama M; Kwee IL; Nakada T
    Pediatrics; 2006 Aug; 118(2):e442-8. PubMed ID: 16882785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent growth failure in Prader-Willi syndrome associated with short-chain acyl-CoA dehydrogenase gene variant.
    Giurgiutiu DV; Espinoza LM; Wood TC; DuPont BR; Holden KR
    J Child Neurol; 2008 Jan; 23(1):112-7. PubMed ID: 18184946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.